In a model of lupus nephritis, the HDAC inhibitor ITF2357 diminished the proinflammatory gene expression of il6, il-1β, and the systemic lupus erythematosus (SLE) serum biomarker IgG2a [65]. This evidence concerns the gene HDAC9 and systemic lupus erythematosus.